Cargando…

Serum and glucocorticoid-regulated kinase 1: Structure, biological functions, and its inhibitors

Serum and glucocorticoid-regulated kinase 1 (SGK1) is a serine/threonine kinase belonging to the protein kinase A, G, and C (AGC) family. Upon initiation of the phosphoinositide 3-kinase (PI3K) signaling pathway, mammalian target of rapamycin complex 2 (mTORC2) and phosphoinositide-dependent protein...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jang, Hyunsoo, Park, Youngjun, Jang, Jaebong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706101/ https://www.ncbi.nlm.nih.gov/pubmed/36457711 http://dx.doi.org/10.3389/fphar.2022.1036844

Ejemplares similares

Azumamides A-E: Isolation, Synthesis, Biological Activity, and Structure–Activity Relationship
por: Jo, Sooheum, et al.
Publicado: (2022)

Striatal miR-183-5p inhibits methamphetamine-induced locomotion by regulating glucocorticoid receptor signaling
por: Song, Sang-Hoon, et al.
Publicado: (2022)

Serum and Glucocorticoid Regulated Kinase 1 in Sodium Homeostasis
por: Lou, Yiyun, et al.
Publicado: (2016)

Inhibition of Spleen Tyrosine Kinase Restores Glucocorticoid Sensitivity to Improve Steroid-Resistant Asthma
por: Liu, Qian, et al.
Publicado: (2022)

Impact of Deleterious Mutations on Structure, Function and Stability of Serum/Glucocorticoid Regulated Kinase 1: A Gene to Diseases Correlation
por: AlAjmi, Mohamed F., et al.
Publicado: (2021)

Advances in RIPK1 kinase inhibitors
por: Chen, Lu, et al.
Publicado: (2022)

The Kinase Specificity of Protein Kinase Inhibitor Peptide
por: Chen, Yao, et al.
Publicado: (2021)

Emerging Role of Serum Glucocorticoid-Regulated Kinase 1 in Pathological Pain
por: Liu, Baowen, et al.
Publicado: (2021)

Cucurbitacin B Induces Hypoglycemic Effect in Diabetic Mice by Regulation of AMP-Activated Protein Kinase Alpha and Glucagon-Like Peptide-1 via Bitter Taste Receptor Signaling
por: Kim, Kang-Hoon, et al.
Publicado: (2018)

Erratum: Advances in RIPK1 kinase inhibitors
Publicado: (2023)

Investigating the role of NPR1 in dilated cardiomyopathy and its potential as a therapeutic target for glucocorticoid therapy
por: Huang, Yaomeng, et al.
Publicado: (2023)

Scaffold Proteins Regulating Extracellular Regulated Kinase Function in Cardiac Hypertrophy and Disease
por: Liang, Yan, et al.
Publicado: (2016)

Novel Pan-Pim Kinase Inhibitors With Imidazopyridazine and Thiazolidinedione Structure Exert Potent Antitumor Activities
por: Sawaguchi, Yuichi, et al.
Publicado: (2021)

Protein phosphatase 6 regulates trametinib sensitivity, a mitogen-activated protein kinase kinase (MEK) inhibitor, by regulating MEK1/2-ERK1/2 signaling in canine melanoma cells
por: YAMAMOTO, Miu, et al.
Publicado: (2023)

A Model of Glucocorticoid Receptor Interaction With Coregulators Predicts Transcriptional Regulation of Target Genes
por: Monczor, Federico, et al.
Publicado: (2019)

Design, synthesis and biological evaluation of novel O-substituted tryptanthrin oxime derivatives as c-Jun N-terminal kinase inhibitors
por: Schepetkin, Igor A., et al.
Publicado: (2022)

Insights Into the Properties, Biological Functions, and Regulation of USP21
por: An, Tao, et al.
Publicado: (2022)

Role of serum- and glucocorticoid-inducible kinase-1 in regulating torsion-induced apoptosis in rats
por: Cho, Y-M, et al.
Publicado: (2011)

Inhibition of serum and glucocorticoid regulated kinase-1 as novel therapy for cardiac arrhythmia disorders
por: Bezzerides, Vassilios J., et al.
Publicado: (2017)

Interaction Between Serum/Glucocorticoid-Regulated Kinase 1 and Interleukin-6 in Chronic Rhinosinusitis
por: Lai, Yuting, et al.
Publicado: (2021)

Expression of serum- and glucocorticoid-regulated kinase 1 and its association with clinicopathological factors and the survival of patients with adenocarcinoma of the esophagogastric junction
por: Gao, Shegan, et al.
Publicado: (2017)

Identification of potential extracellular signal-regulated protein kinase 2 inhibitors based on multiple virtual screening strategies
por: Yang, Ruoqi, et al.
Publicado: (2022)

U0126: Not only a MAPK kinase inhibitor
por: You, Yijie, et al.
Publicado: (2022)

Extracellular signal-regulated kinases 1/2 as regulators of cardiac hypertrophy
por: Mutlak, Michael, et al.
Publicado: (2015)

Effect of cAMP signaling on expression of glucocorticoid receptor, Bim and Bad in glucocorticoid-sensitive and resistant leukemic and multiple myeloma cells
por: Dong, Hongli, et al.
Publicado: (2015)

Recent Advances in the Structural Biology of the Volume-Regulated Anion Channel LRRC8
por: Kasuya, Go, et al.
Publicado: (2022)

Down-Regulation of Serum/Glucocorticoid Regulated Kinase 1 in Colorectal Tumours Is Largely Independent of Promoter Hypermethylation
por: Lessi, Francesca, et al.
Publicado: (2010)

Serum- and glucocorticoid-inducible kinase 1 and the response to cell stress
por: Lang, Florian, et al.
Publicado: (2018)

The Enigmatic Role of Serum & Glucocorticoid Inducible Kinase 1 in the Endometrium
por: Lang, Florian, et al.
Publicado: (2020)

Zebrafish as model system for the biological characterization of CK1 inhibitors
por: Meier, Laura, et al.
Publicado: (2023)

Possible divergence of serum- and glucocorticoid-inducible kinase function in ischemic brain injury
por: Inoue, Koichi
Publicado: (2016)

Discovery of potent and noncovalent KRAS(G12D) inhibitors: Structure-based virtual screening and biological evaluation
por: Wang, Yuting, et al.
Publicado: (2022)

Kinase Inhibitors as Potential Therapeutic Agents in the Treatment of COVID-19
por: Naik, Rajashri R., et al.
Publicado: (2022)

Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma
por: Jiang, Lei, et al.
Publicado: (2023)

Exploring the chemotherapeutic potential of currently used kinase inhibitors: An update
por: Naik, Rajashri R., et al.
Publicado: (2023)

EGFR uncommon alterations in advanced non-small cell lung cancer and structural insights into sensitivity to diverse tyrosine kinase inhibitors
por: Xu, Haiyan, et al.
Publicado: (2022)

Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitor-Associated Cardiotoxicity: A Recent Five-Year Pharmacovigilance Study
por: Liu, Yihan, et al.
Publicado: (2022)

Design, synthesis and biological evaluation of erlotinib-based IDO1 inhibitors
por: Hou, Xi-xi, et al.
Publicado: (2022)

Serum and Glucocorticoid-Inducible Kinase 1 (SGK1) in NSCLC Therapy
por: Guerriero, Ilaria, et al.
Publicado: (2020)

Model-Based Biomarker Selection for Dose Individualization of Tyrosine-Kinase Inhibitors
por: Centanni, Maddalena, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r4ia74qeeo9kaq41ftim39k465